REPLIGEN CORP - COMMON STOCK (RGEN)

Q4 2014 13F Holders as of 12/31/2014

Type / Class
Equity / COMMON STOCK
Shares outstanding
56.2M
Number of holders
165
Total 13F shares, excl. options
29.1M
Shares change
+1.27M
Total reported value, excl. options
$577M
Value change
+$25.2M
Put/Call ratio
0.33
Number of buys
75
Number of sells
-81
Price
$19.80

Significant Holders of REPLIGEN CORP - COMMON STOCK (RGEN) as of Q4 2014

191 filings reported holding RGEN - REPLIGEN CORP - COMMON STOCK as of Q4 2014.
REPLIGEN CORP - COMMON STOCK (RGEN) has 165 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 29.1M shares of 56.2M outstanding shares and own 51.71% of the company stock.
Largest 10 shareholders include FMR LLC (2.53M shares), BlackRock Fund Advisors (2.19M shares), Invesco Ltd. (1.73M shares), DIMENSIONAL FUND ADVISORS LP (1.34M shares), State Street Corp (1.32M shares), VANGUARD GROUP INC (1.19M shares), Conestoga Capital Advisors, LLC (1.13M shares), Ameriprise Financial Inc (1.05M shares), BlackRock Institutional Trust Company, N.A. (956K shares), and ACADIAN ASSET MANAGEMENT LLC (952K shares).
This table shows the top 165 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.